Remote at-home wearable-based gait assessments in Progressive Supranuclear Palsy compared to Parkinson’s Disease

BMC Neurology

Table 2 Gait parameters obtained from 2-min walk test (Mean ± Standard Error)

	PD (n = 10)	PSP (n = 10)	p-value	Cohen’s d
Spatial–Temporal Gait Parameters
Gait Speed, m/s	0.79 ± 0.06	0.45 ± 0.06	< 0.001	1.78
Stride Length, m	0.93 ± 0.08	0.59 ± 0.07	0.002	1.65
Stride Time, s	1.2 ± 0.03	1.4 ± 0.10	0.12	0.74
Cadence, steps/minutes	99.5 ± 2.8	90.2 ± 6.6	0.21	0.58
Total Distance, m	89.6 ± 7.5	49.5 ± 7.3	0.01	1.71
Gait Variability
Gait Speed Variability, m/s	0.17 ± 0.02	0.17 ± 0.02	0.37	0.45
Stride Time Variability, s	0.15 ± 0.03	0.29 ± 0.05	0.13	0.77
Stride Length Variability, m	0.17 ± 0.02	0.20 ± 0.02	0.048	1.04
Phases of Gait
Total Double Support Phase, %	17.5 ± 1.6	28.7 ± 1.8	< 0.001	2.19
Double Support Phase Left, %	8.0 ± 1.0	13.9 ± 1.8	0.012	1.30
Double Support Phase Right, %	9.5 ± 1.0	14.7 ± 0.6	< 0.001	1.97
Stance Phase Left, %	59.4 ± 0.6	63.6 ± 1.2	0.006	1.40
Stance Phase Right, %	58.0 ± 0.9	65.1 ± 1.0	< 0.001	2.27
Swing Phase Left, %	40.6 ± 0.6	36.4 ± 1.2	0.006	1.39
Swing Phase Right, %	41.9 ± 0.9	34.9 ± 1.0	< 0.001	2.27

m represents distance in meters, s represents time in seconds; gait parameters with p values < 0.001 were considered significantly different and are shown in bold; PD Parkinson’s Disease and PSP Progressive supranuclear palsy

ISSN: 1471-2377